The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; BMSi; Cardinal Health; Celgene; Celldex; CStone Pharmaceuticals; Daiichi Sankyo; Epic Sciences; Genentech/Roche; GlaxoSmithKline; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Pfizer; Prescient Therapeutics
Speakers' Bureau - Certara Inc; Eisai
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Rhenium Medical; Roche/Genentech
 
Anne M. O'Neill
No Relationships to Disclose
 
Noah Graham
No Relationships to Disclose
 
Donald W. Northfelt
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Chau T. Dang
Honoraria - eviCore healthcare; Puma Biotechnology
Consulting or Advisory Role - eviCore healthcare; Puma Biotechnology
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Antonio C. Wolff
Consulting or Advisory Role - Ionis Pharmaceuticals
Research Funding - Biomarin (Inst); Celldex (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Pionyr; Syndax; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; GRAIL; Symphogen; Synaffix; Syndax; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Tessa Therapeutics; Verseau Therapeutics
 
Kathy Miller
Consulting or Advisory Role - Athenex; Genentech/Roche; Merck
Research Funding - Astex Pharmaceuticals (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)